Ovid Therapeutics
OVID
#9154
Rank
โ‚ฌ97.07 M
Marketcap
1,36ย โ‚ฌ
Share price
-1.23%
Change (1 day)
25.95%
Change (1 year)

Operating Margin for Ovid Therapeutics (OVID)

Operating Margin as of December 2025 (TTM): -574.01%

According to Ovid Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -574.01%. At the end of 2024 the company had an Operating Margin of -10,933.57%.

Operating Margin history for Ovid Therapeutics from 2022 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-10,933.57%-27.7%
2023-15,122.70%309.12%
2022-3,696.40%-6301.32%
202159.61%-109.24%
2020-645.40%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
ORIC Pharmaceuticals
ORIC
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.